Cytomegalovirus-related childhood mortality in Australia 1999-2011

Journal of Paediatrics and Child Health

Volumn 51, Issue 9, 2015, Pages 901-905

  Smithers Sheedy, Hayley ^a,b,c   Raynes Greenow, Camille ^a,b   Badawi, Nadia ^a,b,c   Khandaker, Gulam ^a,b,d   Menzies, Robert ^a,b   Jones, Cheryl A ^a,b,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d University of Sydney   (Australia)

Author keywords

Australia; cytomegalovirus; mortality

Indexed keywords

ADOLESCENT; ARTICLE; AUSTRALIA; CAUSE OF DEATH; CHILD; CHILD DEATH; CHILDHOOD MORTALITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; HEALTH CARE PLANNING; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS TRANSMISSION; CYTOMEGALOVIRUS; EPIDEMIOLOGY; MORTALITY; PRESCHOOL CHILD;

AUSTRALIA; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; MALE;

EID: 84940788671     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12896     Document Type: Article

References (20)

1. Cannon MJ, Schmid DS, Hyde TB,. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 2010; 20: 202-213.
2. Seale H, MacIntyre CR, Gidding HF, Backhouse JL, Dwyer DE, Gilbert L,. National serosurvey of cytomegalovirus in Australia. Clin. Vaccine Immunol. 2006; 13: 1181-1184.
3. McMullan BJ, Palasanthiran P, Jones CA, et-al. Congenital cytomegalovirus-time to diagnosis, management and clinical sequelae in Australia: opportunities for earlier identification. Med. J. Aust. 2011; 194: 625-629.
4. Townsend CL, Forsgren M, Ahlfors K, Ivarsson SA, Tookey PA, Peckham CS,. Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin. Infect. Dis. 2013; 56: 1232-1239.
5. Dollard SC, Grosse SD, Ross DS,. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 2007; 17: 355-363.
6. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK,. The 'silent' global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 2013; 26: 86-102.
7. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA,. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr. Infect. Dis. J. 1992; 11: 93-99.
8. Lanzieri TM, Dollard SC, Josephson CD, Schmid DS, Bialek SR,. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics 2013; 131: e1937-1945.
9. Nijman J, de Vries LS, Koopman-Esseboom C, Uiterwaal CS, van Loon AM, Verboon-Maciolek MA,. Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings. Arch. Dis. Child. Fetal Neonatal Ed. 2012; 97: F259-263.
10. Hodson EM, Jones CA, Webster AC, et-al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 2005; 365: 2105-2115.
11. Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC,. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst. Rev. 2013; 2: CD003774.
12. Seale H, Macintyre CR, Dwyer DE, Wang H,. The changing epidemiology of severe cytomegalovirus disease in Australia. Hum. Vaccin. 2007; 3: 239-244.
13. Cameron NA, Gormley ME Jr, Deshpande S,. Severity of disability in patients with cerebral palsy secondary to symptomatic congenital cytomegalovirus encephalopathy. J. Pediatr. Rehabil. Med. 2013; 6: 239-242.
14. Cannon MJ, Davis KF,. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005; 5: 70.
15. Stratton K, Durch J, Lawrence R, eds. Vaccines for the 21st Century, A tool for decision-making. Washington, D.C.: Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee to Study Priorities for Vaccine Development, 2000.
16. Bristow BN, O'Keefe KA, Shafir SC, Sorvillo FJ,. Congenital cytomegalovirus mortality in the United States, 1990-2006. PLoS Negl. Trop. Dis. 2011; 5: e1140.
17. Basha J, Iwasenko JM, Robertson P, Craig ME, Rawlinson WD,. Congenital cytomegalovirus infection is associated with high maternal socio-economic status and corresponding low maternal cytomegalovirus seropositivity. J. Paediatr. Child Health 2014; 50: 368-372.
18. Freemantle CJ, Read AW, de Klerk NH, McAullay D, Anderson IP, Stanley FJ,. Patterns, trends, and increasing disparities in mortality for Aboriginal and non-Aboriginal infants born in Western Australia, 1980-2001: population database study. Lancet 2006; 367: 1758-1766.
19. Smithers-Sheedy H, Raynes-Greenow C, Badawi N, McIntyre S, Jones CA,. Congenital cytomegalovirus is associated with severe forms of cerebral palsy and female sex in a retrospective population-based study. Dev. Med. Child Neurol. 2014; 56: 846-852.
20. Williams EJ, Embleton ND, Clark JE, Bythell M, Ward Platt MP, Berrington JE,. Viral infections: contributions to late fetal death, stillbirth, and infant death. J. Pediatr. 2013; 163: 424-428.